As the use of weight loss drugs continues to rise, new health concerns are emerging about the safety of medications known as GLP-1 receptor agonists. Recent research indicates that these drugs may lead to serious blood pressure issues, necessitating careful monitoring.
How Do GLP-1 Drugs Impact Blood Pressure?
A recent study involving over 42,000 individuals on blood pressure medication aimed to determine the effects of GLP-1 drugs like Semaglutide, Tirzepatide, and Liraglutide. The study found a noticeable increase in cases of severe low blood pressure, including dizziness, fainting, and falls, following the initiation of these medications.
The rise in low blood pressure incidents was not solely due to weight loss but also linked to mechanisms involving the autonomic nervous system and the subcortical brain region.
Who is Most at Risk?
The study showed that individuals over 65 and those with type 2 diabetes are at higher risk for low blood pressure. These groups account for a significant portion of recorded incidents despite being a smaller part of the overall sample. This is attributed to arterial stiffness and pre-existing vascular issues in older adults, as well as autonomic nervous system dysfunction in diabetic patients.
Challenges in Remote Healthcare Systems
Researchers expressed concerns about the use of these drugs through electronic prescriptions without direct medical supervision. This system could lead to inadequate blood pressure monitoring, increasing the risk of serious incidents such as head injuries or car accidents.
Recommendations for Patients and Doctors
Doctors should exercise caution when prescribing GLP-1 drugs, especially to patients already on blood pressure medications. Treatment should include gradually reducing previous medications to prevent sharp drops in blood pressure. Patients are advised to avoid relying solely on electronic prescriptions and to work with specialized doctors to monitor their health.
Conclusion
While GLP-1 drugs remain effective in improving metabolic health and reducing heart disease risks, their use requires caution and constant monitoring to avoid serious side effects. Doctors and patients must collaborate to ensure the safe use of these medications and prevent potential risks associated with blood pressure changes.